title: Studies assessing risk of treatments for diabetes mellitus and adverse pregnancy outcomes should control for known risk factors.
authors.forename: E
authors.initials: E
authors.lastname: Edson-Heredia
authors.forename: R D
authors.initials: RD
authors.lastname: Rohwer
authors.forename: M
authors.initials: M
authors.lastname: Wong
authors.forename: P
authors.initials: P
authors.lastname: Wang
authors.forename: A
authors.initials: A
authors.lastname: Vambergue
authors.forename: V
authors.initials: V
authors.lastname: Koivisto
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D007003:Hypoglycemia / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D061268:Insulin Lispro / Q000627:therapeutic use*; D061386:Insulin, Regular, Human / Q000627:therapeutic use*; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*
chemical_list: D007004:Hypoglycemic Agents; D061268:Insulin Lispro; D061386:Insulin, Regular, Human